Tenaya Therapeutics
Anna Greenwood has a diverse work experience starting with their role as a Laboratory Assistant at Molecular Matrix, Inc. from November 2014 to January 2016. Anna then worked at JUUL Labs, where they held the positions of R&D Test Coordinator from September 2017 to January 2019, and Biochemistry RA from January 2019 to June 2020. Currently, Anna is employed at Tenaya Therapeutics, where they began as an RA II, Biology Gene Therapy in July 2020 and later promoted to Senior Research Associate, Biology Gene Therapy in January 2022.
Anna Greenwood completed their Bachelor of Science in Biotechnology from the University of California, Davis, from 2012 to 2016. Anna then pursued a Master of Science in Biotechnology from the University of San Francisco, from 2017 to 2019.
Tenaya Therapeutics
2 followers
Tenaya Therapeutics is a privately-held biopharmaceutical company backed by The Column Group. The Company was founded in 2016 by world-leading scientists from the Gladstone Institute’s Cardiovascular Division and the University of Texas Southwestern Medical Center.